
Big Pharma’s China gamble
FT News Briefing
00:00
Navigating the Challenges of Pharmaceutical Ties to China
This chapter explores China's significant influence in the pharmaceutical sector, noting that Chinese companies account for 18% of global licensing deals. It also examines the dual challenges of cost savings through partnerships versus the risks posed by U.S. tariffs on these collaborations.
Transcript
Play full episode